These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 7629551)
1. Transferable resistance to cefotaxime in nosocomial Klebsiella pneumoniae and Escherichia coli strains due to their production of extended-spectrum beta-lactamase in Slovakia. Hupková M; Blahová J; Babálová M; Krcméry V; Králiková K J Chemother; 1995 Feb; 7(1):16-20. PubMed ID: 7629551 [TBL] [Abstract][Full Text] [Related]
2. Transfer of resistance to oxy-imino-cephalosporins and of extended-spectrum beta-lactamase productions in Klebsiella pneumoniae strains from infected neonates. Blahová J; Hupková M; Králiková K; Krcméry V; Lísková A; Kubonová K Zentralbl Bakteriol; 1998 Jul; 288(1):75-86. PubMed ID: 9728407 [TBL] [Abstract][Full Text] [Related]
3. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures]. Zarakolu P; Metan G; Hasçelik G; Akova M Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077 [TBL] [Abstract][Full Text] [Related]
4. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital. Basak S; Mallick SK; Bose S J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468 [TBL] [Abstract][Full Text] [Related]
5. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli. Duttaroy B; Mehta S Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790 [TBL] [Abstract][Full Text] [Related]
6. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919 [TBL] [Abstract][Full Text] [Related]
7. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases. Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086 [TBL] [Abstract][Full Text] [Related]
8. [Typing of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. strains and analysis of plasmid profiles]. Oksüz L; Gürler N Mikrobiyol Bul; 2009 Apr; 43(2):183-94. PubMed ID: 19621602 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Park SY; Kang CI; Joo EJ; Ha YE; Wi YM; Chung DR; Peck KR; Lee NY; Song JH Microb Drug Resist; 2012 Oct; 18(5):518-24. PubMed ID: 22742454 [TBL] [Abstract][Full Text] [Related]
10. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Shanthi M; Sekar U J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008 [TBL] [Abstract][Full Text] [Related]
12. Hospital cross-transmission of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae. Cholley P; Thouverez M; Gbaguidi-Haore H; Sauget M; Slekovec C; Bertrand X; Talon D; Hocquet D Med Mal Infect; 2013 Aug; 43(8):331-6. PubMed ID: 23876202 [TBL] [Abstract][Full Text] [Related]
13. Genetic characterisation of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from stem cell transplant patients in Tunisia. Abbassi MS; Torres C; Achour W; Vinué L; Sáenz Y; Costa D; Bouchami O; Ben Hassen A Int J Antimicrob Agents; 2008 Oct; 32(4):308-14. PubMed ID: 18620848 [TBL] [Abstract][Full Text] [Related]
14. Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea. Jeong SH; Bae IK; Kwon SB; Lee JH; Jung HI; Song JS; Jeong BC; Kim SJ; Lee SH Lett Appl Microbiol; 2004; 39(1):41-7. PubMed ID: 15189286 [TBL] [Abstract][Full Text] [Related]
15. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A; J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of efficiency of screening extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent. Lee K; Lim JK; Yong D; Yum J; Chong Y; Okamoto R; Inoue M J Clin Microbiol; 2001 Oct; 39(10):3696-9. PubMed ID: 11574594 [TBL] [Abstract][Full Text] [Related]
18. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Lautenbach E; Patel JB; Bilker WB; Edelstein PH; Fishman NO Clin Infect Dis; 2001 Apr; 32(8):1162-71. PubMed ID: 11283805 [TBL] [Abstract][Full Text] [Related]
19. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan. Wachino J; Doi Y; Yamane K; Shibata N; Yagi T; Kubota T; Ito H; Arakawa Y Antimicrob Agents Chemother; 2004 Jun; 48(6):1960-7. PubMed ID: 15155185 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital. Koksal F; Ak K; Kucukbasmaci O; Samasti M Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]